PAM II OF COVINGTON — History
CCN 192048 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+13.8%
Revenue CAGR (3yr)
4.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $16M | $19M | $20M | +4.4% | +13.8% |
| Operating Expenses | $16M | $19M | $19M | +0.7% | +10.4% |
| Operating Margin | -1.1% | 1.5% | 4.9% | +235.3% | +0.0% |
| Net Income | $-0M | $0M | $1M | +249.9% | +0.0% |
| Licensed Beds | 58 | 42 | 31 | -26.2% | -26.9% |
| Total Patient Days | 9,322 | 7,313 | 7,366 | +0.7% | -11.1% |
| Medicare Day % | 59% | 55% | 62% | +13.6% | +3.0% |
| Medicaid Day % | 0% | 2% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +29.6% ($16M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+13.8%
This Hospital
+7.6%
State Avg
Latest Margin
4.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | 8.0% |
| FY2024 (proj) | $25M | 11.0% |
| FY2025 (proj) | $27M | 14.1% |